New effort launched to personalize medicine in heart treatment

Dallas Mon Nov 18, 2013 8:35am IST

A replica of a human heart, constructed of gel, is shown at the European Society of Cardiology meeting venue in Amsterdam September 2, 2013. REUTERS/Cris Toala Olivares/Files

A replica of a human heart, constructed of gel, is shown at the European Society of Cardiology meeting venue in Amsterdam September 2, 2013.

Credit: Reuters/Cris Toala Olivares/Files

Related Topics

Dallas (Reuters) - Cardiologists are taking aim at treating and preventing heart disease, the world's No. 1 killer, with a more personalized approach under a new research collaboration that will marry data with the evolving understanding of genetics.

The effort, being billed as Heart Studies v2.0 and which was announced on Sunday, will be a collaboration of the American Heart Association (AHA) along with Boston University and the University of Mississippi, which oversee ongoing landmark population studies, the Framingham Heart Study and the Jackson Heart Study, respectively.

"The vast participant data base from these important studies, plus additional genetic components, puts us on a path to defining specific risk determinants for certain cardiovascular diseases for every person," said Dr. Joseph Loscalzo, chairman of the AHA Science Oversight Group for the collaboration and chairman of the Department of Medicine at Brigham and Women's Hospital in Boston.

The collaboration hopes to build on the population studies by adding more and more diverse subjects, more genetic analysis and new approaches to gathering data to better understand why treatments work for some people and not others.

It will, for example, take deeper looks into clinical trials to identify precisely which people are likely to benefit from a particular drug or therapy whether the original trial was positive or negative.

Dr. Dan Jones, chancellor of the University of Mississippi and former lead investigator of the Jackson Heart Study, cited an experimental blood pressure medicine that failed to help patients overall in a large clinical trial. Despite the overall failure, five of his patients had dramatically positive responses to the drug.

"The blunt instrument of that trial design wasn't able to determine why," he recalled with obvious frustration.

He said he hoped that Heart Studies v2.0 will be able to determine why some people respond so that appropriate courses of treatment for individual patients could be determined in the future.

"It moves us closer to the day when this leading cause of death can be prevented in more people," he said of the effort announced at the American Heart Association scientific meeting in Dallas.

The Framingham Heart Study began in 1948 with about 5,000 people living in that Massachusetts community west of Boston. It has now followed three generations of Framingham residents and yielded a wealth of information.

The Jackson Heart Study, based in Mississippi and begun in 2000, is the largest heart study ever to focus on African Americans, who tend to be at disproportionate risk of heart disease and stroke.

Asked if a more personalized approach to cardiac care might significantly add to the healthcare cost burden of heart patient treatment, Loscalzo said, "It doesn't necessarily mean you have to use new therapies. It might mean we can use existing therapies smarter."

(Reporting by Bill Berkrot; Editing by Leslie Adler)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Election 2014

REUTERS SHOWCASE

Mobile Tariff Up

Mobile Tariff Up

RComm to raise mobile call tariff by up to 20 percent.  Full Article 

Ukraine Crisis

Ukraine Crisis

Ukraine tightens grip on eastern town before talks.  Full Article 

Ferry Sinks

Ferry Sinks

More than 300 people missing after South Korea ferry sinks - coastguard.  Full Article 

Missing MH370

Missing MH370

Ocean floor search for missing Malaysia plane cut short again.  Full Article 

New Direction

New Direction

New CEO Nadella pushes data culture at Microsoft .  Full Article 

Champions League

Champions League

Podolski double gets Arsenal back into top four.  Full Article 

Miley Unwell

Miley Unwell

Miley Cyrus hospitalized for allergic reaction, cancels Kansas City show.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage